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SCIENTIFIC OPINION 
Scientific Opinion on the annual post-market environmental monitoring 
(PMEM) report from Monsanto Europe S.A. on the cultivation of 
genetically modified maize MON 810 in 2013
1
  
EFSA Panel on Genetically Modified Organisms (GMO)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Genetically Modified Organisms of the 
European Food Safety Authority (EFSA GMO Panel) assessed the post-market environmental monitoring 
(PMEM) report for the 2013 growing season of maize MON 810 provided by Monsanto Europe S.A. The EFSA 
GMO Panel concludes that the data related to insect resistance monitoring does not indicate a significant and 
consistent decrease in susceptibility of the target pest field populations to Cry1Ab protein in Spain over the 2013 
growing season. However, considering that the methodology for insect resistance monitoring remained 
unchanged compared to previous PMEM reports, the EFSA GMO Panel reiterates its previous recommendations 
for improvement of the insect resistance management plan of maize MON 810. The EFSA GMO Panel also 
recommends, as part of general surveillance, the continuation of the screening and discussion of literature on 
possible adverse effects of maize MON 810 on rove beetles. In the absence of information on the general 
surveillance of maize MON 810 in 2013, the EFSA GMO Panel cannot conclude on potential unanticipated 
adverse effects due to the cultivation of maize MON 810 in 2013, or on possible changes to the methodology as 
compared to previous growing seasons.  
© European Food Safety Authority, 2015 
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SUMMARY 
Following a request from the European Commission, the Panel on Genetically Modified Organisms of 
the European Food Safety Authority (EFSA GMO Panel) assessed the post-market environmental 
monitoring (PMEM) report for the 2013 growing season of maize MON 810 provided by Monsanto 
Europe S.A. 
In the absence of information on the general surveillance of maize MON 810 over the 2013 growing 
season, the EFSA GMO Panel cannot conclude on potential unanticipated adverse effects due to the 
cultivation of maize MON 810 in 2013, or on possible changes to the methodology as compared to 
previous growing seasons. However, the EFSA GMO Panel reiterates all its previous 
recommendations pertaining to the general surveillance of maize MON 810 for consideration by the 
applicant. 
The EFSA GMO Panel focused its assessment on the novel 2013 datasets (i.e. data from monitoring 
changes in baseline susceptibility of target pests, information on refugia compliance in Spain and 
Portugal, and outcomes of the literature review on possible adverse effects of maize MON 810 on rove 
beetles). The EFSA GMO Panel concludes that the 2013 data analysis does not indicate a significant 
and consistent decrease in susceptibility of the target pest field populations to Cry1Ab in Spain over 
the 2013 growing season. Considering that the methodology for insect resistance monitoring remained 
unchanged compared to previous PMEM reports, the EFSA GMO Panel reiterates its previous 
recommendations for improvement of the insect resistance management plan of maize MON 810, in 
particular the recommendation for annual sampling of both bi-/multi-voltine target pests in areas 
where maize MON 810 adoption rate is ≥ 50%. 
The EFSA GMO Panel also recommends, as part of general surveillance, the continuation of the 
screening and discussion of literature on possible adverse effects of maize MON 810 on rove beetles. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
The marketing of maize MON 810 (notification C/F/95/12-02) was authorised under Directive 
90/220/EEC
4
 in the European Union (EU) for all, other than food, uses by the Commission Decision 
98/294/EC
5
 of 22 April 1998. Consent was granted to the applicant (Monsanto Europe S.A.) by France 
on 3 August 1998. Food uses of maize derivatives were notified according to Article 5 of the Novel 
Food Regulation (EC) No 258/97
6
 on 6 February 1998.  
On 15 June 2009, the Scientific Panel on Genetically Modified Organisms of the European Food 
Safety Authority (hereafter referred to as EFSA GMO Panel) issued a scientific opinion on the 
renewal of the authorisation for the continued marketing of: (1) existing food and food ingredients 
produced from maize MON 810; (2) feed consisting of and/or containing maize MON 810, including 
the use of seed for cultivation; and (3) food and feed additives, and feed materials produced from 
maize MON 810. The EFSA GMO Panel concluded that ‘maize MON 810 is as safe as its 
conventional counterpart with respect to potential effects on human and animal health’, and that 
‘maize MON 810 is unlikely to have any adverse effect on the environment in the context of its 
intended uses, especially if appropriate management measures are put in place in order to mitigate 
possible exposure of non-target (NT) Lepidoptera’. The EFSA GMO Panel recommended that 
‘especially in areas of abundance of non-target Lepidoptera populations, the adoption of the 
cultivation of maize MON 810 be accompanied by management measures in order to mitigate the 
possible exposure of these species to maize MON 810 pollen’. In addition, the EFSA GMO Panel 
advised that ‘resistance management strategies continue to be employed and that the evolution of 
resistance in lepidopteran target pests continues to be monitored, in order to detect potential changes in 
resistance levels in pest populations’ (EFSA, 2009). 
The EFSA GMO Panel further supplemented its risk assessment conclusions and risk management 
recommendations on non-target Lepidoptera exposed to genetically modified (GM) maize pollen by 
reapplying the mathematical model developed by Perry et al. (2010, 2011, 2012). The EFSA GMO 
Panel also provides additional information on the factors affecting the insect resistance management 
(IRM) strategy (EFSA Panel on Genetically Modified Organisms, 2011b, 2012d). 
From 2005 onwards, the applicant submitted to the European Commission its annual post-market 
environmental monitoring (PMEM) reports on the cultivation of maize MON 810. 
Since 2010, the European Commission asked the EFSA GMO Panel to assess the PMEM reports 
submitted by Monsanto on the cultivation of maize MON 810. The EFSA GMO Panel therefore 
adopted a scientific opinion on the 2009, 2010, 2011 and 2012 PMEM reports (EFSA GMO Panel, 
2011b, 2012a, 2013, 2014). From the data provided in those reports, the EFSA GMO Panel did not 
identify adverse effects on the environment, human and animal health due to maize MON 810 
cultivation. However, the EFSA GMO Panel noted shortcomings in the methodology and hence made 
recommendations for improvement of the PMEM of maize MON 810.  
On 14 November 2014, the EFSA GMO Panel received from the European Commission a request to 
assess the PMEM report submitted by Monsanto on the cultivation of maize MON 810 in 2013. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
The European Commission asked the EFSA GMO Panel ‘to evaluate the findings of the monitoring 
activities, taking into consideration the comments received from Member States and to assess the 
appropriateness of the methodology if this is found to differ compared to the previous season’. 
                                                     
4 Council Directive 90/220/EEC of 23 April 1990 on the deliberate release into the environment of genetically modified 
organisms. OJ L 117, 8.5.1990, p. 15–27. 
5 Commission Decision of 22 April 1998 concerning the placing on the market of genetically modified maize (Zea mays L. 
line MON810), pursuant to Council Directive 90/220/EEC (98/294/EC). OJ L 131, 5.5.1998, p. 32–33. 
6 Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and 
novel food ingredients. OJ L 43, 14.2.1997, p. 1–9. 
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ASSESSMENT 
1. Introduction 
Upon request of the European Commission, the EFSA GMO Panel assessed the PMEM report
7
 on the 
2013 growing season of maize MON 810 (hereafter referred to as ‘2013 PMEM report’) taking into 
consideration the comments received from Member States on the 2013 PMEM report. 
In 2013, maize MON 810 was cultivated in the Czech Republic (2560 ha), Portugal (8202 ha), 
Romania (835 ha), Slovakia (100 ha) and Spain (136 962 ha) over a total area of approximately 
148 659 hectares. 
2. Overview of information provided by the applicant 
The 2013 PMEM report differs from previous reports as the applicant did not report on the general 
surveillance of maize MON 810 during the 2013 growing season. In contrast to its previous reports, 
the applicant did not submit the raw data from the survey of farmers who cultivated maize MON 810 
in 2013, nor an overview of the scientific papers on maize MON 810 or the related insecticidal 
Cry1Ab protein published between June 2013 and June 2014.     
The applicant reported on the outcomes of:   
– the insect resistance management (IRM) plan8 consisting of: (1) the ‘high dose-refuge’ 
strategy, including surveys
9
 on farmers’ compliance with non-Bt refugia; (2) the monitoring 
for changes in baseline susceptibility of target pests and the diagnostic dose
10
 (DD) assays
11
; 
(3) a communication and education plan of farmers; (4) a remedial action plan in the event of 
any confirmed evolution of pest resistance; 
– the company stewardship activities;  
– the search for publications related to possible adverse effects of maize MON 810 on rove 
beetles (Coleoptera: Staphylinidae) as follow-up to a previous recommendation of the EFSA 
GMO Panel (EFSA, 2014).  
Based on the weight of evidence available, the applicant concluded that: (1) ‘there are no adverse 
effects attributed to the cultivation of maize MON 810 in Europe’, and that (2) ‘the result of 2013 
monitoring concurs with the results observed since monitoring was started in 2003’. 
3. Assessment 
In the absence of information on the general surveillance of maize MON 810 over the 2013 growing 
season, the EFSA GMO Panel cannot conclude on potential unanticipated adverse effects due to the 
cultivation of maize MON 810 in 2013. The EFSA GMO Panel is therefore not in the position to 
conclude on possible changes to the methodology followed by the applicant as compared to previous 
growing seasons. However, the EFSA GMO Panel reiterates all its previous recommendations 
pertaining to the general surveillance of maize MON 810 for consideration by the applicant (EFSA 
GMO Panel, 2011b, 2012a, 2013, 2014). 
                                                     
7 The 2013 PMEM report is published online: http://ec.europa.eu/food/plant/gmo/reports_studies/report_2013_mon_810_en.htm 
8 2013 PMEM report, Appendix 1. 
9  2013 PMEM report, Appendix 2. 
10 The diagnostic dose (DD) is the dose that causes 99% of moulting inhibition to first instar larvae (MIC99). 
11 2013 PMEM report, Appendices 3 and 4. 
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In this scientific opinion, the EFSA GMO Panel focused its assessment on the novel datasets as 
provided in the 2013 PMEM report, i.e. 
(1)  the survey12 carried out by the applicant to check farmers compliance with non-Bt refugia 
implementation in the five EU countries where maize MON 810 was cultivated in 2013; 
(2)  the report by Portuguese authorities on farmers compliance with non-Bt refugia 
implementation over the 2013 growing season; 
(3)  Spanish data13 from monitoring changes in baseline susceptibility of target pests (i.e. European 
corn borer (ECB; Ostrinia nubilalis Hübner) and Mediterranean corn borer (MCB; Sesamia 
nonagrioides Lefebvre)) in 2013, and the assays with the DD; 
(4)  the overview and analysis of publications related to possible adverse effects of maize MON 
810 on rove beetles.  
Following the terms of reference of the mandate from the European Commission, the EFSA GMO 
Panel also considered whether the methodology used by the applicant to monitor maize MON 810 
over the 2013 growing season differs from the methodology applied by the applicant in its PMEM 
reports for the 2009, 2010, 2011 and 2012 growing seasons of maize MON 810 (EFSA GMO Panel, 
2011b, 2012a, 2013, 2014). 
3.1. Implementation of non-Bt refugia 
The EFSA GMO Panel analysed the results of the farmer survey addressing the implementation of 
non-Bt refugia. The applicant asked 256 farmers from four EU countries where maize MON 810 was 
cultivated in 2013 (Czech Republic, Romania, Portugal and Spain), to compile a questionnaire on the 
planting of non-Bt refugia. In Czech Republic, Portugal, and Romania, all farmers surveyed (66 in 
total) confirmed that non-Bt refugia were planted. In Spain, 12.5% of the farmers surveyed (190 in 
total) did not plant a refuge area even though there were required to. They provided the following two 
reasons for not planting a refuge area: (1) farmers were not informed about technical guidelines, and 
(2) the sowing is easier without the refuge area. 
The results of the Spanish farmer’s survey could not be corroborated to a similar study carried out by 
ANTAMA, the Spanish Foundation supporting the use of new technologies in agriculture, as provided 
in previous PMEM reports. 
In 2013, the Portuguese authorities carried out an independent survey of 113 farmers (out of the 232 
notifications received in 2013) cultivating maize MON 810 for control of good implementation of 
Portuguese law pertaining to cultivation of GM varieties. They concluded that there was full 
compliance with refuge implementation. 
The 2013 PMEM report shows partial compliance with the implementation of non-Bt refugia in Spain. 
The EFSA GMO Panel therefore recommends that the applicant should maintain its efforts to increase 
the level of compliance, especially in regions of high maize MON 810 uptake. In this context, the 
education and training program of the farming community in managing maize MON 810 as proposed 
by the applicant is paramount.  
3.2. Monitoring for changes in baseline susceptibility of target pests 
The applicant monitored possible changes in baseline susceptibility of the target pests to Cry1Ab 
protein in North-East Spain (for both ECB and MCB) and Central Spain (for ECB only) by measuring 
the Moulting Inhibiting Concentrations (MIC50 and MIC90). The applicant concluded that ‘differences 
found in the susceptibility to the toxin are within the range of variability expected for field collections 
of these corn borers. Further, the analyses of historical series of susceptibility data of S. nonagrioides 
                                                     
12 2013 PMEM report, Appendix 2 
13 2013 PMEM report, Appendices 3 and 4 
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or O. nubilalis to Cry1Ab did not reveal signs of changed susceptibility to this toxin by field 
collections from the sampling the areas considered’. 
In the 2013 PMEM report, only MIC values were provided. Even though MIC values are more 
sensitive and precise than LC
14
 values, the EFSA GMO Panel reiterates its previous recommendation 
to provide both LC and MIC values in future PMEM reports (EFSA GMO Panel, 2012).  
As part of the harmonised IRM plan,
15
 the applicant proposed to sample multivoltine target pest 
populations every two years in areas where maize MON 810 adoption rate varies between 20% and 
80% of the total maize cultivated area. Annual sampling is foreseen only in exceptional circumstances 
in areas of high uptake (i.e. > 80% and therefore in areas where non-Bt refugia have not been 
implemented). In order to ensure an early detection of change in susceptibility of the ECB and MCB 
field populations, the EFSA GMO Panel reiterates its previous recommendation for annual sampling 
of both bi-/multi-voltine target pests in areas where maize MON 810 adoption rate is ≥ 50% (see 
Table 1 in EFSA, 2014).  
The EFSA GMO Panel noted that a new Cry1Ab toxin batch was used for bioassays with ECB in 
2013. The applicant verified the biological activity of the batches of protein used in the bioassays with 
field populations and concluded that the old toxin batch, used in 2011, and the new toxin batch, used 
in 2013, have similar biological activity. 
The EFSA GMO Panel evaluated how the applicant addressed its previous recommendation to further 
investigate the stability and quality of the reference laboratory strain of O. nubilalis (for further 
details, EFSA GMO Panel, 2014). In its 2013 PMEM report, the applicant did not explicitly discuss 
the stability and quality of the reference laboratory strain, although some information regarding such 
matter can be extracted from Appendices 3 and 4. According to the applicant,
16
 the reference 
laboratory strain of O. nubilalis that have been used in the bioassays since 2011 (namely G.04) seems 
to present egg-masses of good quality and adults of normal size. These parameters could indicate that 
the fitness of such strain was not reduced. However, experimental data corroborating such statement 
are not given (e.g. fitness parameters across generations, such as developmental time, pupal weight, 
fecundity, fertility). In addition, PCR analysis provided by the applicant showed that the strain G.04 is 
not infected by Nosema, a known pathogen of O. nubilalis. The applicant checked the quality of the 
reference laboratory strain which demonstrated acceptable performance in bioassays in 2013. 
During the assessment of the 2012 PMEM report, a specific analysis
17
 carried out by the French Haut 
Conseil des Biotechnologies (HCB) suggested a hypothesised increased tolerance of target pests in 
Spain when compared with the reference laboratory strain (EFSA, 2014). This could be explained by 
e.g.: (1) any type of change in the insecticidal Cry1Ab protein attributed to target pests (e.g. more or 
less toxic); (2) a modification (e.g. weakening) of the reference laboratory strain; and (3) an increased 
tolerance of the Spanish target pest populations to the Cry1Ab protein. The 2013 data for ECB do not 
confirm the assumption of increased tolerance of target pests to Cry1Ab protein in Spain (see Table 1). 
                                                     
14 Lethal concentrations (LC).  
15 2013 PMEM report, see Table 4 in Appendix 1. 
16 2013 PMEM report, Appendix 4. 
17 Available at : http://www.hautconseildesbiotechnologies.fr/IMG/pdf/131108_Surveillance_mais_MON810_2012_
Commentaires_CS_HCB.pdf 
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Table 1:  Resistance ratios18 of Ostrinia nubilalis populations sampled in 2009, 2011 and 2013 
1 Data provided by the applicant showed that the Cry1Ab toxin batches B1 and B2, and B2 and B3 have similar biological 
activity. 
 
The MIC50 and MIC90 values reported in 2013 for MCB are in the range of those obtained in previous 
years. The EFSA GMO Panel concludes that the 2013 data analysis does not indicate a significant and 
consistent decrease in susceptibility of the target pest field populations to Cry1Ab protein in Spain 
(see Table 2). 
Table 2:  Resistance ratios19 of Sesamia nonagrioides populations sampled in 2007, 2009, 2011 and 
2013  
 
Moreover, the EFSA GMO Panel already advised that, once regular measurement of the susceptibility 
baseline is implemented, changes in the frequency of resistance alleles should also be reported (EFSA, 
2013). The EFSA GMO Panel therefore welcomes the preliminary assay provided by the applicant 
based on the DD and encourages him to provide DD assays in future PMEM reports. However, further 
details on the methodology (e.g. number of individuals tested) should be provided for sake of an 
appropriate assessment of the results.  
3.3. Analysis of papers on possible effects of maize MON 810 on rove beetles 
In response to a previous recommendation from the EFSA GMO Panel (EFSA GMO Panel, 2014), the 
applicant listed and analysed relevant publications (Albajes et al., 2012, 2013; Comas et al., 2014; 
                                                     
18 The resistance ratio is calculated between susceptibility values for O. nubilalis collected from North-East and Central Iberia 
and for the susceptible laboratory strain for each growing season. 
19 The resistance ratio is calculated between susceptibility values for S. nonagrioides collected from North-East Iberia and for 
the susceptible laboratory strain for each growing season. 
Population Season 
Toxin 
batch1 
MIC50 MIC90 
Resistance 
ratio 
MIC50 
Resistance 
ratio 
MIC90 
North-East 
Iberia 
2009 B1 6.40 13.68 1.75 1.40 
2011 B2 1.79 4.19 0.29 0.24 
2013 B3 2.48 5.41 1.26 0.82 
Central 
Iberia 
2009 B1 3.09 11.98 0.85 1.25 
2011 B2 1.56 4.04 0.26 0.23 
2013 B3 2.40 6.38 1.22 0.97 
Laboratory  
2009 B1 3.65 9.56   
2011 B2 6.08 17.43   
2013 B3 1.96 6.57   
Population Season Toxin batch MIC50 MIC90 
Resistance 
ratio 
MIC50 
Resistance 
ratio 
MIC90 
North-East 
Iberia 
2007 B1 14 99 0.87 1.05 
2009 B1 22 188 1.16 1.56 
2011 B2 20 135 2.22 1.98 
2013 B2 19 163 2.7 3.39 
Reference 
laboratory 
strain 
2007 B1 16 94   
2009 B1 19 120   
2011 B2 9 68   
2013 B2 7 48   
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Twardowski et al., 2014) related to possible adverse effects of maize MON 810 on rove beetles. Based 
on the aforementioned publications, the specificity of the Cry1Ab protein to Lepidoptera, and the 
heterogenous distribution of rove beetles in maize fields, the applicant concluded that the observed 
difference in rove beetles abundance in maize MON 810 fields reported by Albajes et al. (2012) are 
unlikely to be attributed to the Cry1Ab protein.  
Considering various data reporting the highly variable distribution of rove beetles over time and space 
(e.g. de la Poza et al., 2005; Balog et al., 2010), the EFSA GMO Panel recommends, as part of general 
surveillance, the continuation of the literature screening and discussion of literature on possible 
adverse effects of maize MON 810 on rove beetles. 
4. Conclusions and recommendations 
In the absence of information on the general surveillance of maize MON 810 over the 2013 growing 
season, the EFSA GMO Panel cannot conclude on potential unanticipated adverse effects due to the 
cultivation of maize MON 810 in 2013, or on possible changes to the methodology as compared to 
previous growing seasons. However, the EFSA GMO Panel reiterates all its previous 
recommendations pertaining to the general surveillance of maize MON 810 for consideration by the 
applicant (EFSA GMO Panel, 2011b, 2012a, 2013, 2014). 
The EFSA GMO Panel focused its assessment on the novel 2013 datasets (i.e. data from monitoring 
changes in baseline susceptibility of target pests, information on refugia compliance in Spain and 
Portugal, and outcomes of the literature review on possible adverse effects of maize MON 810 on rove 
beetles). The EFSA GMO Panel concludes that the 2013 data analysis does not indicate a significant 
and consistent decrease in susceptibility of the target pest field populations to Cry1Ab protein in Spain 
over the 2013 growing season. Considering that the methodology for insect resistance monitoring 
remained unchanged compared to previous reports, the EFSA GMO Panel reiterates its previous 
recommendations for improvement of the insect resistance management plan of maize MON 810, in 
particular the recommendation for annual sampling of both bi-/multi-voltine target pests in areas 
where maize MON 810 adoption rate is ≥ 50%. 
The EFSA GMO Panel also recommends, as part of general surveillance, the continuation of the 
screening and discussion of literature on possible adverse effects of maize MON 810 on rove beetles. 
OVERALL CONCLUSIONS AND RECOMMENDATIONS 
In the absence of information on the general surveillance of maize MON 810 over the 2013 growing 
season, the EFSA GMO Panel cannot conclude on potential unanticipated adverse effects due to the 
cultivation of maize MON 810 in 2013 or on possible changes to the methodology as compared to 
previous growing seasons. 
The data related to insect resistance management, submitted by the applicant in its 2013 PMEM 
report, does not indicate a significant and consistent decrease in susceptibility of the target pest field 
populations to Cry1Ab protein in Spain over the 2013 growing season. 
DOCUMENTATION PROVIDED TO EFSA 
1. Letter from the European Commission, dated 13 November 2014, to the EFSA Executive Director 
requesting the assessment of the MON 810 monitoring report for the 2013 cultivation season 
provided by Monsanto; the 2013 PMEM report was annexed to the letter. 
2. Comments from Member States on the PMEM report for cultivation of maize MON 810 in 2013. 
3. Acknowledgement letter, dated 1 December 2014, from the EFSA Executive Director to the 
European Commission. 
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